ALLTERUM

Anti-cancer preparations; Biological preparations for the treatment of cancer; Biopharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of hematologic malignancies; Pharmaceutical preparations in the form of injectables for the treatment of cancer; Pharmaceutical preparations for immunotherapy; Pharmaceutical preparations for the treatment of metabolic and cardiometabolic diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of acute lymphoblastic leukemia; Pharmaceutical products for the treatment of cancer